Showing results (231-240 of 600) with videos related to
Sort By:
Pageof 60
Molecular Immunology|February 27, 2022
Prohibitin plays a role in the functional plasticity of macrophagesYang Xin Zi Xu, Sudharsana Rao Ande, Nnamdi M Ikeogu, et al.Nature Communications|October 10, 2025
A next-generation anti-CTLA-4 probody mitigates toxicity and enhances anti-tumor immunity in miceWeian Cao, Junfan Chen, Yutong Fu, et al.Cancer Letters|May 7, 2026
IL-12 Augments Adoptive Cell Therapy by Reshaping CD8<sup>+</sup> T Dynamics and Broadening Antitumor ImmunityYue Huang, Xiangming Liu, Yiwei Chen, et al.The Journal of Clinical Investigation|February 1, 2022
Selective delivery of low-affinity IL-2 to PD-1+ T cells rejuvenates antitumor immunity with reduced toxicityZhenhua Ren, Anli Zhang, Zhichen Sun, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2002
Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of experimental autoimmune encephalomyelitisYonglian Sun, Xiaoqi Lin, Helen M Chen, et al.The Review of Scientific Instruments|September 1, 2022
A miniatured helical antenna based on the sinusoidal folding structure with exponential spacingYang-Xin Qiu, Yan-Zhao Xie, Shao-Fei Wang, et al.Nature Reviews. Cancer|August 30, 2019
Phagocytosis checkpoints as new targets for cancer immunotherapyMingye Feng, Wen Jiang, Betty Y S Kim, et al.Thrombosis Research|February 8, 2011
Tumor necrosis factor-alpha G-308A gene polymorphism and coronary heart disease susceptibility: an updated meta-analysisHai-Feng Zhang, Shuang-Lun Xie, Jing-Feng Wang, et al.European Journal of Immunology|September 16, 2004
A role for lymphotoxin in the acquisition of Ly49 receptors during NK cell developmentRebecca H Lian, Robert K Chin, Hajnalka E Nemeth, et al.Nature Communications|May 14, 2015
Effector lymphocyte-induced lymph node-like vasculature enables naive T-cell entry into tumours and enhanced anti-tumour immunityJ David Peske, Elizabeth D Thompson, Lelisa Gemta, et al.Pageof 60